ARCHIVES

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

This article is from The Cancer Letter archive.

Vol. 24 No. 03 | January 23, 1998

Download PDF Visit The Full Archive

Related Articles

Breast Density As Important As Age In Determining Risk

September 29, 2006

New Funding Mechanisms – Cooperative Agreement, Consortium Grant – Proposed For Clinical Groups

April 6, 1979

In the States: Michigan to Allocate $50 Million Annually To Life Sciences

July 23, 1999

Craig Thompson Of Abramson Center Named President, CEO, Of Memorial Sloan-Kettering

September 3, 2010

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

February 25, 2011

BSA Approves Concept For Ovarian Cancer SPORE Grant

June 26, 1998